EGFR and colorectal carcinoma: To correlate in vitro Cetuximab treatment responses to potential alterations of the target structure, i.e. EGFR itself, EGFR mRNA and protein expression as well as EGFR promoter methylation were assessed in all seven CRC cell lines (Figure 2).